4th Quarter - Report — EPILEPSY FOUNDATION for EPILEPSY FOUNDATION (2017)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

EPILEPSY FOUNDATION

Client

EPILEPSY FOUNDATION

Income

—

Expenses

$60,000

Expense method

B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
4th Quarter - Report (this page)	Nov 30, 2017	$60,000	Replaced
4th Quarter - Amendment	Mar 13, 2018	$60,000	Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Civil Rights/Civil Liberties CIV

ADA, employment discrimination, access to education, ending stigma surrounding epilepsy, disability rights

Lobbyist	Covered position, as disclosed
BEATRIZ DUQUE	—
JENNA A MATHIS New	—
ANGELA OSTROM	—

Contacted: Drug Enforcement Administration (DEA); SENATE; White House Office; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

Health care reform, Medicare, Medicaid, access to care

Lobbyist	Covered position, as disclosed
BEATRIZ DUQUE	—
JENNA A MATHIS New	—
ANGELA OSTROM	—

Contacted: White House Office; SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Budget/Appropriations BUD

NIH, CDC, FDA and health care/public health appropriations

Lobbyist	Covered position, as disclosed
BEATRIZ DUQUE	—
JENNA A MATHIS New	—
ANGELA OSTROM	—

Contacted: White House Office; SENATE; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.